Comprison of Iontophoresis and phonophoresis of Dexamethasone in the patient with Carpal Tunnel Syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138706251254N1

Enrollment

Registered

2009-03-09

Start date

2007-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome (CTS). Carpal tunnel syndrome

Interventions

Phonophoresis of Dexamethazone

Iontophoresis of Dexamethazone

Intervention 1: Phonophoresis of Dexamethazone. Intervention 2: Iontophoresis of Dexamethazone.

Treatment - Devices

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: mild or moderate Carpal Tunnel Syndrome. Exclusion Criteria: Severe Carpal Tunnel Syndrome, any form of pervious treatment or having any neuromuscular or skeletal problem in the upper limb, Diabetic condition.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sensory and motor conduction of Median nerve. Timepoint: before and after 15 session of intervention. Method of measurement: Nerve cunduction study.	—

Secondary

Measure	Time frame
Muscle weakness. Timepoint: before and after 15 session of intervention. Method of measurement: maximum voluntary contraction force of tip to tip pinch.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Bakhtiary

Rehabilitation faculty

amirbakhtiary@sem-ums.ac.ir+98 23 1444 1983

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026